# Montreal Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device

> **NCT00571610** · PHASE1 · COMPLETED · sponsor: **Viacor** · enrollment: 5 (actual)

## Conditions studied

- Heart Failure
- Mitral Regurgitation

## Interventions

- **DEVICE:** PTMA (Percutaneous Transvenous Mitral Annuloplasty) Implant

## Key facts

- **NCT ID:** NCT00571610
- **Lead sponsor:** Viacor
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2008-04
- **Final completion:** 2008-11
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2008-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00571610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00571610, "Montreal Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00571610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*